GlassScriptPhysician profile
Wesley W Bryan
NPI 1720070568
$15,264.98
in general payments reported to CMS, 2019-2025
47 companies · $2,220 in 2025
The $2,220 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,148 · 2020: $778 · 2021: $1,085 · 2022: $2,039 · 2023: $3,974 · 2024: $3,020 · 2025: $2,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,998 · Travel and Lodging: $1,112 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,997.78 |
| Travel and Lodging | $1,112.15 |
| Education | $104.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $3,748.33 | 2019-2025 | Titan, Altis, Restorelle |
| Teleflex LLC | $2,732.84 | 2021-2024 | Urolift |
| Axonics, INC. | $1,182.79 | 2020-2024 | Axonics, Bulkamid |
| Neotract INC. | $1,031.35 | 2019-2020 | |
| Astellas Pharma US INC | $903.99 | 2019-2024 | Myrbetriq, Xtandi |
| Boston Scientific Corporation | $575.69 | 2019-2025 | Solyx Sis System, Ams 700, Advance Xp |
| Janssen Biotech, INC. | $527.68 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $510.38 | 2023-2025 | Gemtesa |
| Calyxo, INC. | $376.23 | 2025 | Cvac Aspiration System |
| Abbvie INC. | $346.73 | 2019-2025 | Botox |
| Intuitive Surgical, INC. | $262.15 | 2019-2025 | Da Vinci Surgical System |
| Myriad Genetic Laboratories, INC. | $229.05 | 2023 | Prolaris |
| Antares Pharma, INC. | $215.41 | 2019-2025 | Xyosted |
| Allergan, INC. | $199.08 | 2019-2021 | |
| Pfizer INC. | $197.42 | 2019-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $187.35 | 2022-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $183.30 | 2022-2025 | |
| Accord Healthcare, INC. | $164.13 | 2022-2023 | |
| Photocure INC | $160.58 | 2019-2025 | Cysview |
| Procept Biorobotics Corporation | $136.70 | 2024 | Aquabeam System |
| Tolmar Pharmaceuticals, INC. | $116.89 | 2021-2022 | |
| Karl Storz Endoscopy-America | $106.61 | 2020-2021 | |
| Urovant Sciences INC | $104.03 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $100.68 | 2022-2025 | Pylarify |
| Tolmar, INC. | $96.00 | 2024-2025 | Eligard, Jatenzo |
| Blue Earth Diagnostics | $85.18 | 2019-2022 | |
| Ethicon US, LLC | $84.23 | 2023 | Ethicon, Surgicel Nu-Knit, Surgiflo Hemostatic Matrix |
| Ferring Pharmaceuticals INC. | $80.90 | 2019 | |
| Hollister Incorporated | $66.73 | 2022-2024 | |
| Abc Home Medical Supply, INC. | $63.89 | 2022-2024 | |
| Profound Medical Corp. | $62.59 | 2023 | Tulsa-Pro |
| Aytu Biopharma, INC. | $44.77 | 2019 | |
| Cook Medical LLC | $43.64 | 2019-2024 | Resonance |
| Novartis Pharmaceuticals Corporation | $41.48 | 2025 | |
| Innovation Technologies INC | $38.99 | 2024 | Irrisept |
| 180 Medical, INC. | $36.92 | 2024-2025 | Gentlecath Glide |
| Steris Corporation | $30.09 | 2024 | |
| Myovant Sciences INC. | $28.19 | 2022 | |
| Dendreon Pharmaceuticals LLC | $27.37 | 2025 | Provenge |
| Medtronic, INC. | $20.48 | 2025 | Interstim |
| C. R. Bard, INC. & Subsidiaries | $19.40 | 2023 | Bard Urinary Drainage Bag |
| Mission Pharmacal Company | $18.59 | 2023 | Uribel |
| Agiliti Surgical, INC. | $18.17 | 2019 | |
| Acerus Pharmaceuticals Corporation | $16.52 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.00 | 2023 | Seglentis |
| Medtronic USA, INC. | $13.71 | 2019 | |
| Halozyme INC | $12.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.